Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | PLX-4720 | 0.1 | uM | 4 | 2500.00 | 1726.92 | 3717.00 | 3234.50 | 1.1492 | 1.3320 |
| SK-BR-3 | PLX-4720 | 1 | uM | 4 | 2500.00 | 1726.92 | 3448.00 | 3234.50 | 1.0660 | 1.1463 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 4 | 2500.00 | 1726.92 | 3342.00 | 3234.50 | 1.0332 | 1.0735 |
| SK-BR-3 | Nilotinib | 10 | uM | 4 | 2500.00 | 1726.92 | 1614.00 | 3234.50 | 0.4990 | -0.0720 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 4 | 2500.00 | 1726.92 | 3354.00 | 3234.50 | 1.0369 | 1.0818 |
| SK-BR-3 | Etoposide | 19.9526 | uM | 4 | 2500.00 | 1726.92 | 1079.00 | 3234.50 | 0.3336 | -0.4052 |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3360.00 | 3234.50 | 1.0388 | 1.0859 | |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3401.00 | 3234.50 | 1.0515 | 1.1140 | |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3233.00 | 3234.50 | 0.9995 | 0.9990 | |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 2898.00 | 3234.50 | 0.8960 | 0.7715 | |
| SK-BR-3 | Etoposide | 1 | uM | 4 | 2500.00 | 1726.92 | 1475.00 | 3234.50 | 0.4560 | -0.1598 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 4 | 2500.00 | 1726.92 | 3326.00 | 3234.50 | 1.0283 | 1.0626 |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3461.00 | 3234.50 | 1.0700 | 1.1553 | |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 4 | 2500.00 | 1726.92 | 1454.00 | 3234.50 | 0.4495 | -0.1730 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 4 | 2500.00 | 1726.92 | 3164.00 | 3234.50 | 0.9782 | 0.9519 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 4 | 2500.00 | 1726.92 | 3626.00 | 3234.50 | 1.1210 | 1.2690 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 4 | 2500.00 | 1726.92 | 3340.00 | 3234.50 | 1.0326 | 1.0722 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 4 | 2500.00 | 1726.92 | 3328.00 | 3234.50 | 1.0289 | 1.0640 |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 4 | 2500.00 | 1726.92 | 3223.00 | 3234.50 | 0.9964 | 0.9922 |
| SK-BR-3 | Etoposide | 0.1 | uM | 4 | 2500.00 | 1726.92 | 3157.00 | 3234.50 | 0.9760 | 0.9471 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 4 | 2500.00 | 1726.92 | 3797.00 | 3234.50 | 1.1739 | 1.3875 |
| SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3392.00 | 3234.50 | 1.0487 | 1.1078 | |
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 4 | 2500.00 | 1726.92 | 3049.00 | 3234.50 | 0.9427 | 0.8737 |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 4 | 2500.00 | 1726.92 | 3661.00 | 3234.50 | 1.1319 | 1.2932 |
| SK-BR-3 | Nilotinib | 1 | uM | 4 | 2500.00 | 1726.92 | 3328.00 | 3234.50 | 1.0289 | 1.0640 |